Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
grade A 24.69 -3.02% -0.77
BHC closed down 3.02 percent on Friday, March 22, 2019, on 86 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical BHC trend table...

Date Alert Name Type % Chg
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 21 Stochastic Sell Signal Bearish -3.02%
Mar 21 Inside Day Range Contraction -3.02%
Mar 21 BB Squeeze Ended Range Expansion -3.02%
Mar 21 Overbought Stochastic Strength -3.02%
Mar 20 Bollinger Band Squeeze Range Contraction -2.68%
Mar 20 Calm After Storm Range Contraction -2.68%
Mar 20 BB Squeeze + Upper Band Touch Range Contraction -2.68%
Mar 20 Overbought Stochastic Strength -2.68%
Mar 20 Upper Bollinger Band Touch Strength -2.68%

Older signals for BHC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
Biotechnology Life Sciences Laser Organ Systems S&P/Tsx 60 Index Psoriasis Medical Devices Acne Ulcerative Colitis Specialty Drugs Atopic Dermatitis Diarrhea Irritable Bowel Syndrome Hair Removal Generic Pharmaceuticals Over The Counter Products Salix Pharmaceuticals Bausch Health Eye Health Products
Is BHC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 28.45
52 Week Low 14.95
Average Volume 4,166,927
200-Day Moving Average 23.6151
50-Day Moving Average 24.0918
20-Day Moving Average 24.133
10-Day Moving Average 24.562
Average True Range 0.8579
ADX 17.67
+DI 27.2192
-DI 18.0884
Chandelier Exit (Long, 3 ATRs ) 23.7663
Chandelier Exit (Short, 3 ATRs ) 25.3637
Upper Bollinger Band 25.6917
Lower Bollinger Band 22.5743
Percent B (%b) 0.68
BandWidth 12.917582
MACD Line 0.3119
MACD Signal Line 0.1693
MACD Histogram 0.1426
Fundamentals Value
Market Cap 8.61 Billion
Num Shares 349 Million
EPS -3.27
Price-to-Earnings (P/E) Ratio -7.55
Price-to-Sales 0.44
Price-to-Book 1.03
PEG Ratio -0.33
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.10
Resistance 3 (R3) 26.17 25.76 25.87
Resistance 2 (R2) 25.76 25.40 25.73 25.79
Resistance 1 (R1) 25.23 25.18 25.03 25.16 25.71
Pivot Point 24.82 24.82 24.72 24.79 24.82
Support 1 (S1) 24.29 24.46 24.09 24.22 23.67
Support 2 (S2) 23.88 24.24 23.85 23.59
Support 3 (S3) 23.35 23.88 23.52
Support 4 (S4) 23.28